Show results for
Refine by
Human Hormone Articles & Analysis
8 news found
The company’s commitment to supplying high-quality chemicals is reflected in its extensive product line, which includes critical substances like Gibberellic Acid, Lipase, Lactic Acid, Xylan, Human Growth Hormone, and Oat β-Glucan. Each of these products stands as a testament to Alfa Chemistry’s unwavering dedication to scientific excellence and ...
It can be used for the detection of clinical fluids and the monitoring of amino acids, vitamins, exogenous pharmaceuticals, hormones, human trace elements, toxic and detrimental elements, and human trace elements. ...
However, despite the remarkable impact of FDA-approved biologics based on secreted proteins such as insulin, human growth hormone, and erythropoietin, this class of biologics has remained largely understudied and underutilized by biopharma due to low abundance, higher structural complexity, and the massive search space to map secreted proteins to ...
A Phase I clinical study will be conducted in Chinese patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced/metastatic breast cancer, including patients who are resistant to approved CDK4/6 inhibitors, to evaluate the safety, tolerability and pharmacokinetic profile of RGT-419B capsule. ...
The interim analysis will evaluate the safety and annualized height velocity of the three dose levels of LUM-201 against a standard dose of injectable recombinant human growth hormone (rhGH) in 40 subjects at six months on therapy. ...
It is expected to combat the resistance to currently approved CDK4/6 inhibitors that are given in combination with endocrine-based therapy for treatment of pre/perimenopausal or postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced or metastatic breast cancer. The Phase I clinical trial is in ...
It is expected to improve the safety of and combat the resistance to currently approved CDK4/6 inhibitors that are given in combination with endocrine-based therapy for treatment of pre/perimenopausal or postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced or metastatic breast cancer. ...
EPA is proposing to use ground-breaking tools developed in the ToxCast program to improve testing for chemicals that have the potential to disrupt hormone function in the human body. EPA uses automated chemical screening technologies to rapidly and simultaneously perform tests on thousands of chemicals and feed the results into computational models to predict ...